Dietary intervention, but not losartan, completely reverses non-alcoholic steatohepatitis in obese and insulin resistant mice

Jef Verbeek*, Pieter Spincemaille, Ilse Vanhorebeek, Greet Van den Berghe, Ingrid Vander Elst, Petra Windmolders, Jos van Pelt, Schalk van der Merwe, Pierre Bedossa, Frederik Nevens, Bruno Cammue, Karin Thevissen, David Cassiman

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Article number46
Number of pages10
JournalLipids in Health and Disease
Volume16
DOIs
Publication statusPublished - 23 Feb 2017

Keywords

  • NASH
  • treatment
  • Diet
  • Losartan
  • Angiotensin
  • FATTY LIVER-DISEASE
  • II RECEPTOR BLOCKADE
  • LIFE-STYLE
  • WEIGHT-LOSS
  • SCORING SYSTEM
  • FIBROSIS
  • NAFLD
  • TRANSPLANTATION
  • INFLAMMATION

Cite this

Verbeek, J., Spincemaille, P., Vanhorebeek, I., Van den Berghe, G., Vander Elst, I., Windmolders, P., van Pelt, J., van der Merwe, S., Bedossa, P., Nevens, F., Cammue, B., Thevissen, K., & Cassiman, D. (2017). Dietary intervention, but not losartan, completely reverses non-alcoholic steatohepatitis in obese and insulin resistant mice. Lipids in Health and Disease, 16, [46]. https://doi.org/10.1186/s12944-017-0432-7